about
Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart StudyFramingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffnessGenome-wide association with select biomarker traits in the Framingham Heart StudySingle-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart StudyGenetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association dataBiomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortalityGenome-wide association analysis identifies multiple loci related to resting heart rateRare independent mutations in renal salt handling genes contribute to blood pressure variationGenetic variants in novel pathways influence blood pressure and cardiovascular disease riskObesity and the risk of heart failureVisceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart StudyCCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart StudyValidation of a surveillance case definition of carpal tunnel syndromeConsent for genetic research in the Framingham Heart StudyUsing family-based imputation in genome-wide association studies with large complex pedigrees: the Framingham Heart Study.The relation of genetic and environmental factors to systemic inflammatory biomarker concentrationsDuffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators.Association testing of the mitochondrial genome using pedigree data.Genetic analyses of longitudinal phenotype data: a comparison of univariate methods and a multivariate approach.Prevalence and clinical outcome of mitral-valve prolapse.Incidence and prognosis of syncope.Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score.Phenotype-genotype association grid: a convenient method for summarizing multiple association analyses.The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reportsFramingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.Genome-wide association study of electrocardiographic and heart rate variability traits: the Framingham Heart Study.Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities StudiesBrachial artery diameter, blood flow and flow-mediated dilation in sleep-disordered breathing.Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study.Relation of multiple inflammatory biomarkers to incident atrial fibrillation.A three-stage approach for genome-wide association studies with family data for quantitative traitsLongitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community.Uromodulin levels associate with a common UMOD variant and risk for incident CKD.Arterial stiffness and cardiovascular events: the Framingham Heart StudyGenome-wide association study of PR interval.Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levelsRelation of brachial and digital measures of vascular function in the community: the Framingham heart study.Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) ConsortiumPrevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study)Clinical and genetic correlates of circulating angiopoietin-2 and soluble Tie-2 in the community.
P50
Q21093317-4D656BA1-77E8-405E-946E-19F2DE41DF4BQ21093323-F60C7FCD-E270-4F40-A160-4D08D3B258ACQ21261433-7C6F7FCC-D0AB-42DE-B69A-9612F8164EC8Q24338862-BF4B11A7-5E20-4D2E-8504-2A6F2697D1DEQ24612121-AD14537F-05F7-4C40-92B5-D9175E235DDAQ24623768-E44EDAF6-14A5-490E-92E2-61E820B43210Q24624928-C2D50218-5CF6-4B7A-A525-F0F0771C6FAEQ24627187-DF2EF63B-8253-4C2E-9AD5-10C0DF95EE0BQ24630394-E25CD4EC-4A3D-4B7A-ABA9-6A9F52651473Q28216583-1D7C57D5-0F58-42D3-98BD-A56968FAD647Q28219755-71A96143-4E78-4492-9DF6-53A8AFD0D2C3Q28268514-47BED82C-670A-4ACD-9291-775C55B95C0AQ28387950-D212F832-4B0E-4717-91A4-562E5781EADDQ28749646-18EE5BC8-B732-443E-BF76-B496DF1EA96FQ30423046-5E8B80B6-1554-419E-A4F8-E1B200D54D83Q30495275-8617F5EC-4C87-48C9-A6BC-4F12AAB7EF93Q30495417-23A670E7-0F80-42FF-B09F-9166ED2826C4Q30586031-A8C7F8E7-53D6-477F-AE5C-BB4F8AEAAC8FQ30907362-083E9875-8F1A-4A56-9604-38652CC638DAQ33144828-21B3A416-0320-4B01-9DD9-128BF7AE4B1BQ33148118-CAC065C6-9E5B-4E31-ABB0-BE0B7A32B293Q33207407-5FC9F73F-3823-455B-B895-662F4079F8A7Q33244250-21188E88-E2D8-4BAA-B8AF-5B28064F9098Q33300809-897A89CB-569C-422D-9A5E-9B5D371B8945Q33300816-AAA5848E-11BB-4133-BF17-A27E3AC1930CQ33300817-17029042-D594-4C38-9A93-9D8AC0E1244BQ33340170-AF2EF8CB-2264-4228-93E0-F0156AF18913Q33508971-A7259196-062E-4401-9BE5-DE6A4FFED4CCQ33556561-8E9ECA03-8D60-461B-9390-1B5ED33E9B83Q33573035-210FCAAA-0246-4649-B31C-A2D573DE90F2Q33578388-0BFEA0D9-F00A-483C-B9CA-37A18255E93CQ33659377-80694D27-0A0E-44E0-A628-2FC59E052880Q33711244-FC59B1E9-8B87-4DEC-94CE-5549E6AD6397Q33720064-7592D3E5-5E2F-4F3F-AFE5-BF61D5772B3CQ33772170-9DCCD490-E1D9-465E-9E48-913435DAE6B6Q33773714-2B8DE396-C530-4D8B-81EE-AF9CA54ACBEBQ33801973-CC260BE1-B588-4A0C-A4CF-65DADD1C6020Q33817075-F547BD12-B42B-4168-8871-5705E44CE871Q33857670-B13B0CC7-D509-461F-9429-EC07ED26BF89Q33944299-771700F9-E627-48CD-A910-B225CA9B4F84
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin G Larson
@ast
Martin G Larson
@en
Martin G Larson
@es
Martin G Larson
@nl
Martin G Larson
@sl
type
label
Martin G Larson
@ast
Martin G Larson
@en
Martin G Larson
@es
Martin G Larson
@nl
Martin G Larson
@sl
altLabel
Larson MG
@en
prefLabel
Martin G Larson
@ast
Martin G Larson
@en
Martin G Larson
@es
Martin G Larson
@nl
Martin G Larson
@sl
P106
P21
P31
P496
0000-0002-9631-1254